Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK202 in Participants with Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating ALK202 in adults with advanced solid tumors to assess safety, tolerability, pharmacokinetics, and preliminary antitumor activity. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• ALK202 (ALK202)

Snippet

Sponsor: Shanghai Allink Biotherapeutics Co., Ltd. | Conditions: Advanced Cancer, Advanced Solid Tumor | Phase 1 | Status: RECRUITING